Aurora Cannabis (ACB) Capital Expenditures (2017 - 2025)

Aurora Cannabis (ACB) has 9 years of Capital Expenditures data on file, last reported at $23.3 million in Q1 2025.

• Capital Expenditures for Q1 2025 came in at $23.3 million, up 11.68% year-over-year; the trailing twelve-month figure through Mar 2025 was $12.7 million (down 12.91% YoY), and the FY2025 annual result was $13.1 million, up 5.21% from the prior year.
• Capital Expenditures advanced to $23.3 million in Q1 2025 per ACB's latest filing, from -$3.5 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $77.2 million in Q2 2021 and troughed at -$9.6 million in Q1 2021.
• A 5-year average of $4.6 million and a median of -$3.4 million in 2022 frame the typical range for Capital Expenditures.
• On a YoY basis, Capital Expenditures climbed as much as 87.76% in 2022 and fell as far as 105.99% in 2022.
• A 5-year view of Capital Expenditures shows it stood at -$8.9 million in 2021, then jumped by 87.76% to -$1.1 million in 2022, then tumbled by 86.39% to -$2.0 million in 2023, then tumbled by 70.55% to -$3.5 million in 2024, then jumped by 769.6% to $23.3 million in 2025.
• Business Quant data shows ACB's Capital Expenditures at $23.3 million in Q1 2025, -$3.5 million in Q4 2024, and -$3.3 million in Q3 2024.